Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

1.

Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity.

Plimack ER, Hoffman-Censits JH, Viterbo R, Trabulsi EJ, Ross EA, Greenberg RE, Chen DY, Lallas CD, Wong YN, Lin J, Kutikov A, Dotan E, Brennan TA, Palma N, Dulaimi E, Mehrazin R, Boorjian SA, Kelly WK, Uzzo RG, Hudes GR.

J Clin Oncol. 2014 Jun 20;32(18):1895-901. doi: 10.1200/JCO.2013.53.2465. Epub 2014 May 12.

PMID:
24821881
[PubMed - indexed for MEDLINE]
2.

Neoadjuvant dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with pegfilgrastim support in muscle-invasive urothelial cancer: pathologic, radiologic, and biomarker correlates.

Choueiri TK, Jacobus S, Bellmunt J, Qu A, Appleman LJ, Tretter C, Bubley GJ, Stack EC, Signoretti S, Walsh M, Steele G, Hirsch M, Sweeney CJ, Taplin ME, Kibel AS, Krajewski KM, Kantoff PW, Ross RW, Rosenberg JE.

J Clin Oncol. 2014 Jun 20;32(18):1889-94. doi: 10.1200/JCO.2013.52.4785. Epub 2014 May 12.

PMID:
24821883
[PubMed - indexed for MEDLINE]
3.

Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder.

Blick C, Hall P, Pwint T, Al-Terkait F, Crew J, Powles T, Macaulay V, Munro N, Douglas D, Kilbey N, Protheroe A, Chester JD.

Cancer. 2012 Aug 15;118(16):3920-7. doi: 10.1002/cncr.26675. Epub 2012 Jan 3.

PMID:
22614698
[PubMed - indexed for MEDLINE]
Free Article
4.

Adjuvant and neoadjuvant chemotherapy for invasive bladder cancer.

Kuroda M, Meguro N, Maeda O, Saiki S, Kinouchi T, Usami M, Kotake T.

Cancer Chemother Pharmacol. 1994;35 Suppl:S9-13.

PMID:
7527736
[PubMed - indexed for MEDLINE]
5.

Neoadjuvant gemcitabine plus carboplatin for locally advanced bladder cancer.

Iwasaki K, Obara W, Kato Y, Takata R, Tanji S, Fujioka T.

Jpn J Clin Oncol. 2013 Feb;43(2):193-9. doi: 10.1093/jjco/hys213. Epub 2012 Dec 28.

PMID:
23275643
[PubMed - indexed for MEDLINE]
Free Article
6.

Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. International collaboration of trialists.

[No authors listed]

Lancet. 1999 Aug 14;354(9178):533-40. Erratum in: Lancet 1999 Nov 6;354(9190):1650.

PMID:
10470696
[PubMed - indexed for MEDLINE]
7.

Neoadjuvant gemcitabine plus cisplatin for muscle-invasive bladder cancer.

Kaneko G, Kikuchi E, Matsumoto K, Obata J, Nakamura S, Miyajima A, Oya M.

Jpn J Clin Oncol. 2011 Jul;41(7):908-14. doi: 10.1093/jjco/hyr068. Epub 2011 Jun 10.

PMID:
21665907
[PubMed - indexed for MEDLINE]
Free Article
8.

Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: a retrospective analysis from the University of Southern California.

Fairey AS, Daneshmand S, Quinn D, Dorff T, Dorin R, Lieskovsky G, Schuckman A, Cai J, Miranda G, Skinner EC.

Urol Oncol. 2013 Nov;31(8):1737-43. doi: 10.1016/j.urolonc.2012.07.005. Epub 2012 Nov 7.

PMID:
23141776
[PubMed - indexed for MEDLINE]
9.

A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience.

Dash A, Pettus JA 4th, Herr HW, Bochner BH, Dalbagni G, Donat SM, Russo P, Boyle MG, Milowsky MI, Bajorin DF.

Cancer. 2008 Nov 1;113(9):2471-7. doi: 10.1002/cncr.23848.

PMID:
18823036
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin: report of Southwest Oncology Group Trial 8733.

Higano CS, Tangen CM, Sakr WA, Faulkner J, Rivkin SE, Meyers FJ, Hussain M, Baker LH, Russell KJ, Crawford ED; Southwest Oncology Group Trial 8733.

Cancer. 2008 May 15;112(10):2181-7. doi: 10.1002/cncr.23420.

PMID:
18404692
[PubMed - indexed for MEDLINE]
Free Article
11.

Retrospective analysis of the efficacy of two cycles of M-VAC neoadjuvant chemotherapy followed by radical cystectomy for muscle-invasive bladder cancer.

Kitagawa Y, Izumi K, Miwa S, Kadono Y, Konaka H, Mizokami A, Namiki M.

Anticancer Res. 2013 Oct;33(10):4497-503.

PMID:
24123021
[PubMed - indexed for MEDLINE]
12.

Impact of recombinant human granulocyte colony stimulating factor on dose intensity and toxicity of three cycles of methotrexate, vinblastine, doxorubicin and cisplatin in patients with previously untreated urothelial bladder carcinoma.

Viens P, Gravis G, Bladou F, Lechevallier E, Baume D, Camerlo J, Cowen D, Coulange C, Serment G, Resbeut M, Maraninchi D.

Eur Cytokine Netw. 1996 Sep;7(3):395-9.

PMID:
8954183
[PubMed - indexed for MEDLINE]
13.

Neoadjuvant CMV chemotherapy plus radical cystectomy in locally advanced bladder cancer: the impact of pathologic response on long-term results.

Scattoni V, Bolognesi A, Cozzarini C, Francesca F, Grasso M, Galli L, Torelli T, Campo B, Villa E, Rigatti P.

Tumori. 1996 Sep-Oct;82(5):463-9.

PMID:
9063525
[PubMed - indexed for MEDLINE]
14.

The efficacy of neoadjuvant chemotherapy in invasive bladder cancer.

Cam K, Yildirim A, Ozveri H, Turkeri L, Akdas A.

Int Urol Nephrol. 2002;33(1):49-52.

PMID:
12090338
[PubMed - indexed for MEDLINE]
15.

Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.

George L, Bladou F, Bardou VJ, Gravis G, Tallet A, Alzieu C, Serment G, Salem N.

Urology. 2004 Sep;64(3):488-93. Review.

PMID:
15351577
[PubMed - indexed for MEDLINE]
16.

RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy.

Hagan MP, Winter KA, Kaufman DS, Wajsman Z, Zietman AL, Heney NM, Toonkel LM, Jones CU, Roberts JD, Shipley WU.

Int J Radiat Oncol Biol Phys. 2003 Nov 1;57(3):665-72.

PMID:
14529770
[PubMed - indexed for MEDLINE]
17.
18.

[Neoadjuvant and adjuvant chemotherapy of bladder cancer].

Kuroda M, Kotake T.

Gan To Kagaku Ryoho. 1994 Oct;21 Suppl 3:362-9. Review. Japanese.

PMID:
7986116
[PubMed - indexed for MEDLINE]
19.

International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial.

International Collaboration of Trialists; Medical Research Council Advanced Bladder Cancer Working Party (now the National Cancer Research Institute Bladder Cancer Clinical Studies Group); European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group; Australian Bladder Cancer Study Group; National Cancer Institute of Canada Clinical Trials Group; Finnbladder; Norwegian Bladder Cancer Study Group; Club Urologico Espanol de Tratamiento Oncologico Group, Griffiths G, Hall R, Sylvester R, Raghavan D, Parmar MK.

J Clin Oncol. 2011 Jun 1;29(16):2171-7. doi: 10.1200/JCO.2010.32.3139. Epub 2011 Apr 18.

PMID:
21502557
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Everything old is new again! Neoadjuvant chemotherapy in the treatment of muscle-invasive bladder cancer.

Sternberg CN, Apolo AB.

J Clin Oncol. 2014 Jun 20;32(18):1868-70. doi: 10.1200/JCO.2014.55.4055. Epub 2014 May 12. No abstract available.

PMID:
24821880
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk